Regulations.gov document
FDA's Meeting Granted Letter to Clariant Corporation and Clariant Produkte (Deutschland)…
Other · FDA-2004-N-0037 · posted Apr 29, 2016
Key facts
| Document ID | FDA-2004-N-0037-0013 |
|---|---|
| Title | FDA's Meeting Granted Letter to Clariant Corporation and Clariant Produkte (Deutschland) GmbH (Clariant) regarding Piroctone Olamine |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2004-N-0037 |
| Posted | Apr 29, 2016 |
| Comment period opens | Apr 29, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: